Hepatocyte protection & liver function

What actually decides this outcome, in order of size

Hepatoprotection is only meaningful against an injury that is happening. Ranked by how much of the outcome each one owns:

1. Whether the hepatocyte is currently being injured, and by what. Alcohol, visceral adiposity, a drug on the current list and iron overload account for most of what this page is bought for. Withdrawing the agent is the intervention with the largest effect and it is not on the shelf. Weight loss through lifestyle modification significantly reduced the histologic features of steatohepatitis Vilar-Gomez 2015, which is a size of effect nothing else here has demonstrated.
2. What the transaminase you were measured against actually means. The upper reference limit for alanine aminotransferase has been re-derived against histology in a metabolic cohort and it is lower than the interval most laboratories print Choi 2024. A result inside the printed range is therefore not proof of an uninjured liver, and a result above it is not proof of one that needs a supplement.
3. Whether there is fibrosis behind the enzymes, because that is the question with a prognosis attached. A sequential approach using FIB-4 and then the enhanced liver fibrosis panel has been evaluated for predicting advanced fibrosis Kang 2024. Enzymes describe activity; fibrosis describes accumulated damage, and they can move in opposite directions.
4. The single most-sold item on the page has a negative trial in the population with the most to gain. A randomized, placebo-controlled trial of silymarin in patients with chronic hepatitis C who had failed interferon therapy did not reduce serum alanine aminotransferase Fried 2012. That is the strongest test milk thistle has been given, and it is the test it lost.
5. Absorption, which quietly decides whether most of this list is a dose at all. Silybin is poorly soluble and heavily conjugated on first pass; free silybin is a small fraction of what is swallowed Wen 2008, and the bioavailability question has been re-examined in its own right Javed 2011. Oral glutathione has the same problem in a more extreme form.

The order to run these in, and what has to be true first

Find the injury, remove it, measure what it did, and only then decide whether anything on the shelf has a job. Buying first is how somebody spends a year on a botanical while the cause continues.

1. One panel, before anything. Comprehensive Metabolic Panel (CMP) carries the transaminases, alkaline phosphatase, bilirubin and albumin. Add GGT (Gamma-Glutamyl Transferase), which is the most alcohol-sensitive of the routine enzymes and the one that most often separates a metabolic from a toxic pattern. Add Ferritin with the Iron Panel (Iron, TIBC, Transferrin Saturation), because iron overload is a treatable cause that looks exactly like everything else here.
2. Then stage rather than guess. If the enzymes are abnormal, Enhanced Liver Fibrosis (ELF) Test answers the fibrosis question that the enzymes cannot Kang 2024. This is the step that changes what happens next, and it is the step readers skip in favor of a capsule.
3. Remove the agent that is producing the picture. Alcohol first, then a medication review with whoever prescribed them, then visceral adiposity, where the histologic response is a function of how much weight actually comes off Vilar-Gomez 2015. None of these is purchasable and all three outrank the rest of this list.
4. NAC is the only molecule on this page with an established hepatic indication, and it is not this one. It is the antidote in paracetamol poisoning, given intravenously, on a nomogram, in a hospital. Its use as a daily cysteine donor is a different and much weaker proposition; glycine plus N-acetylcysteine in older adults has been studied as a glutathione-precursor pair Kumar 2023.
5. Glutathione is a synthesis problem, not a supply problem. Glutathione is made intracellularly from glutamate, cysteine and glycine, and cysteine is the rate-limiting substrate. A liposomal preparation did raise body stores in a controlled study Sinha 2018, which is a real finding about that formulation and not about capsules in general.
6. Milk Thistle (Siliphos) after the above, and with the trial in mind. If it is used, a standardized silybin-phospholipid preparation is the one with the pharmacokinetic argument Wen 2008, and the expectation should be set by Fried 2012 rather than by the packaging.
7. Artichoke Leaf Extract and Dandelion Root are choleretic and lipid-directed rather than hepatoprotective. Artichoke extracts have a lipid-lowering meta-analysis Sahebkar 2018; dandelion root's hepatic evidence is preclinical Pfingstgraf 2021. Both are reasonable and neither protects a hepatocyte in any demonstrated sense.
8. TUDCA, Schisandra, Alpha Lipoic Acid, Vitamin E, Choline Bitartrate, Livagen and Svetinorm are the mechanistic tail. Each has a plausible target and none has a randomized hepatic outcome in a general population. Liver Support and MediClear (Detox Shake) are blends and are judged on their components against this same order.

What gets bought for this that cannot move it

The category fails when there is nothing to protect. A hepatoprotectant is a rescue agent, and rescue in an uninjured cell is not a smaller effect, it is no effect. Most readers of this page have a normal Comprehensive Metabolic Panel (CMP), no fibrosis and an exposure history of two drinks a week. For them the entire shelf is a subscription to a benefit that requires an injury they do not have — and the honest read-out is the normal panel itself, not a supplement.

Oral glutathione is the option whose marketing most exceeds its pharmacology. It is a tripeptide entering a gut full of peptidases, and the intestinal and hepatic handling of it is why the field works with precursors instead Kumar 2023. Where a formulation has been shown to raise stores it was a specific liposomal preparation in a controlled study Sinha 2018, which is a claim about that product rather than about the ingredient.

And a normal liver panel is a result, not a failed test. This is the most useful sentence on the page. A normal Comprehensive Metabolic Panel (CMP) with a normal GGT (Gamma-Glutamyl Transferase) in somebody worried about their liver closes a question that would otherwise absorb years of purchases, and the updated reference work means the interval it is read against has actually been examined Choi 2024.

If the reason you are here is different, so is the page. Fat in the liver on a scan is Hepatic fat & fatty liver. A hangover and its aftermath is Alcohol, acetaldehyde & recovery. Wanting to clear something specific is Phase II conjugation — the step that actually clears things, and interrupting reabsorption is Binders & interrupting reabsorption. Jaundice, dark urine, pale stool or right-upper-quadrant pain is a clinician this week.

How you would know it was working, on a real read-out and a real timescale

The prediction this page makes is narrow and testable. If a hepatoprotectant is doing anything measurable, an ELEVATED transaminase should fall over roughly one hepatocyte turnover while the cause is held constant. If the enzymes were normal to start with, nothing here has a read-out and the honest answer is that the page cannot tell you whether it worked.

• Comprehensive Metabolic Panel (CMP) at baseline and again at 12 weeks. Twelve weeks because circulating alanine aminotransferase has a half-life of roughly two days and the hepatocyte population itself turns over on the order of months, so an eight-week retest is reading a transient and a two-week retest is reading noise.
• GGT (Gamma-Glutamyl Transferase) with the same draws, and read it as an exposure meter. It is induced by alcohol and by several drugs and it falls over weeks after the exposure stops. A falling GGT alongside an unchanged supplement regimen usually means the drinking changed, which is worth knowing and is not what was bought.
• Enhanced Liver Fibrosis (ELF) Test only if the enzymes or the imaging raised the fibrosis question Kang 2024. It is a staging test, not a monitoring test, and repeating it at three months answers nothing because fibrosis does not move on that timescale.
• Ferritin with hs-CRP (High-Sensitivity C-Reactive Protein), once. Ferritin is an acute-phase reactant, so a raised value in an inflamed person is not iron overload, and a genuinely high transferrin saturation on the Iron Panel (Iron, TIBC, Transferrin Saturation) is a different diagnosis with a different treatment.
• HbA1c (Hemoglobin A1c) and the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) once, because the commonest hepatocyte injury in this readership is metabolic. They also give the weight-loss lever a number attached to it Vilar-Gomez 2015.

What will fool you. Transaminases rise for two or three days after unaccustomed heavy exercise because skeletal muscle contains alanine aminotransferase too, so a draw taken the morning after leg day reads like liver injury. Alcohol intake almost always falls when somebody starts taking a liver supplement, and the enzymes follow the alcohol. Statins and several antibiotics move the same numbers. And silymarin products differ enormously in free silybin content Javed 2011, so a null result on one capsule says nothing about the compound and a positive one says nothing about the shelf.

Sources read for these sections

• Fried MW. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy. JAMA 2012 · PMID 22797645
• Javed S. Reassessing bioavailability of silymarin. Alternative Medicine Review 2011 · PMID 21951025
• Wen Z. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metabolism and Disposition 2008 · PMID 17913795
• Choi J, et al. Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population. Clinical Gastroenterology and Hepatology 2024 · PMID 38750867
• Vilar-Gomez E, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology 2015;149(2):367-78 · PMID 25865049
• Kang YW, et al. Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Diagnostics 2024 · PMID 39594183
• Sahebkar A. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2018 · PMID 28609140
• Pfingstgraf IO. Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure. Antioxidants (Basel) 2021 · PMID 33804908
• Sinha R, Sinha I, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition 2018 · PMID 28853742
• Kumar P. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. Journals of Gerontology Series A 2023 · PMID 35975308